Literature DB >> 19870737

OBSERVATIONS ON THE PATHOLOGICAL CHANGES FOLLOWING EXPERIMENTAL HYPERTENSION PRODUCED BY CONSTRICTION OF THE RENAL ARTERY.

C G Child1.   

Abstract

The clinical histories and pathological findings of six animals dying within a few days following bilateral constriction of the renal arteries have been presented. No explanation for the rise in blood pressure was found. The clinical histories and pathological findings of twelve animals with a sustained hypertension have been considered together with the detailed account of one of these in which a marked degree of arterial disease was found. It has been suggested from the study of this group that, though no cause for the initiation of the hypertension was found, the induced arterial disease might account for its maintenance.

Entities:  

Year:  1938        PMID: 19870737      PMCID: PMC2133609          DOI: 10.1084/jem.67.4.521

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  1 in total

1.  STUDIES ON EXPERIMENTAL HYPERTENSION : I. THE PRODUCTION OF PERSISTENT ELEVATION OF SYSTOLIC BLOOD PRESSURE BY MEANS OF RENAL ISCHEMIA.

Authors:  H Goldblatt; J Lynch; R F Hanzal; W W Summerville
Journal:  J Exp Med       Date:  1934-02-28       Impact factor: 14.307

  1 in total
  4 in total

1.  [Hypertension and kidneys].

Authors:  G W PICKERING
Journal:  Klin Wochenschr       Date:  1955-04-15

2.  The aetiology of essential hypertension.

Authors:  M F LOCKETT
Journal:  Postgrad Med J       Date:  1945-10       Impact factor: 2.401

3.  THE DEPRESSOR EFFECT OF SPLENO-RENO-PEXY ON HYPERTENSION DUE TO RENAL ISCHEMIA.

Authors:  D M Weeks; A Steiner; J S Mansfield; J Victor
Journal:  J Exp Med       Date:  1940-09-30       Impact factor: 14.307

4.  EXPERIMENTAL HYPERTENSION : THE EFFECTS OF UNILATERAL RENAL ISCHEMIA COMBINED WITH INTESTINAL ISCHEMIA ON THE ARTERIAL BLOOD PRESSURE.

Authors:  A Blalock; S E Levy; R D Cressman
Journal:  J Exp Med       Date:  1939-05-31       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.